Literature DB >> 8416367

Differentiated liver cell specificity of the second enhancer of hepatitis B virus.

C H Yuh1, L P Ting.   

Abstract

Hepatitis B virus is a hepatotropic virus. Its replication and gene expression are mainly restricted to hepatocytes in the infective process. The viral gene expression thus provides a unique system with which to study the control of tissue-specific gene expression. We have previously reported the identification and characterization of the second enhancer (enhancer II) of hepatitis B virus. In this report, we further demonstrate that the minimal functional constituents of the second enhancer, box alpha and box beta, display liver cell and differentiation state specificity. Moreover, box alpha exhibits the same liver cell and differentiation state specificity when functioning as an upstream regulator for the basal core promoter. Gel shift experiments reveal a unique box alpha-binding protein, protein a, which is present only in differentiated liver cells, where enhancer II is functional. The converse is true for another box alpha-binding protein, protein f, which is present only in poorly differentiated liver cells and nonliver cells. The simplest hypothesis that explains these results is that protein a activates and/or protein f suppresses the enhancer and upstream regulator functions. Although C/EBP is a candidate for a transcription factor that interacts with box alpha or box beta, none of the binding factors identified in the gel shift assays, including protein a and protein f, is likely to be C/EBP because they differ from C/EBP in heat lability and sequence preference.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8416367      PMCID: PMC237346     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  44 in total

1.  Expression of hepatitis B viral core region in mammalian cells.

Authors:  M J Roossinck; S Jameel; S H Loukin; A Siddiqui
Journal:  Mol Cell Biol       Date:  1986-05       Impact factor: 4.272

2.  Production of hepatitis B virus by a differentiated human hepatoma cell line after transfection with cloned circular HBV DNA.

Authors:  C Sureau; J L Romet-Lemonne; J I Mullins; M Essex
Journal:  Cell       Date:  1986-10-10       Impact factor: 41.582

3.  Replication of the genome of a hepatitis B--like virus by reverse transcription of an RNA intermediate.

Authors:  J Summers; W S Mason
Journal:  Cell       Date:  1982-06       Impact factor: 41.582

4.  The gene S promoter of hepatitis B virus confers constitutive gene expression.

Authors:  Y Malpièce; M L Michel; G Carloni; M Revel; P Tiollais; J Weissenbach
Journal:  Nucleic Acids Res       Date:  1983-07-11       Impact factor: 16.971

5.  A 58-base-pair region of the human C3 gene confers synergistic inducibility by interleukin-1 and interleukin-6.

Authors:  D R Wilson; T S Juan; M D Wilde; G H Fey; G J Darlington
Journal:  Mol Cell Biol       Date:  1990-12       Impact factor: 4.272

6.  Hepatitis B virus (HBV) particles are produced in a cell culture system by transient expression of transfected HBV DNA.

Authors:  K Yaginuma; Y Shirakata; M Kobayashi; K Koike
Journal:  Proc Natl Acad Sci U S A       Date:  1987-05       Impact factor: 11.205

7.  Stable expression and replication of hepatitis B virus genome in an integrated state in a human hepatoma cell line transfected with the cloned viral DNA.

Authors:  T Tsurimoto; A Fujiyama; K Matsubara
Journal:  Proc Natl Acad Sci U S A       Date:  1987-01       Impact factor: 11.205

8.  The genome of hepatitis B virus contains a second enhancer: cooperation of two elements within this enhancer is required for its function.

Authors:  C H Yuh; L P Ting
Journal:  J Virol       Date:  1990-09       Impact factor: 5.103

Review 9.  The hepatitis B virus.

Authors:  P Tiollais; C Pourcel; A Dejean
Journal:  Nature       Date:  1985 Oct 10-16       Impact factor: 49.962

10.  Biochemical and genetic evidence for the hepatitis B virus replication strategy.

Authors:  C Seeger; D Ganem; H E Varmus
Journal:  Science       Date:  1986-04-25       Impact factor: 47.728

View more
  13 in total

1.  Transcriptional repression of human hepatitis B virus genes by a bZIP family member, E4BP4.

Authors:  C K Lai; L P Ting
Journal:  J Virol       Date:  1999-04       Impact factor: 5.103

2.  Temporal acquisition of sequential mutations in the enhancer II and basal core promoter of HBV in individuals at high risk for hepatocellular carcinoma.

Authors:  Xin Bai; Yu Zhu; Yan Jin; Xia Guo; Gengsun Qian; Taoyang Chen; Jing Zhang; Jinbing Wang; John D Groopman; Jianren Gu; Hong Tu
Journal:  Carcinogenesis       Date:  2010-09-28       Impact factor: 4.944

3.  Cellular factors controlling the activity of woodchuck hepatitis virus enhancer II.

Authors:  K Ueda; Y Wei; D Ganem
Journal:  J Virol       Date:  1996-07       Impact factor: 5.103

4.  Identification of multiple transcription factors, HLF, FTF, and E4BP4, controlling hepatitis B virus enhancer II.

Authors:  H Ishida; K Ueda; K Ohkawa; Y Kanazawa; A Hosui; F Nakanishi; E Mita; A Kasahara; Y Sasaki; M Hori; N Hayashi
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

5.  Woodchuck hepatitis virus contains a tripartite posttranscriptional regulatory element.

Authors:  J E Donello; J E Loeb; T J Hope
Journal:  J Virol       Date:  1998-06       Impact factor: 5.103

6.  In vivo activity of the hepatitis B virus core promoter: tissue specificity and temporal regulation.

Authors:  O Billet; G Grimber; M Levrero; K A Seye; P Briand; V Joulin
Journal:  J Virol       Date:  1995-09       Impact factor: 5.103

7.  In vivo regulation of hepatitis B virus replication by peroxisome proliferators.

Authors:  L G Guidotti; C M Eggers; A K Raney; S Y Chi; J M Peters; F J Gonzalez; A McLachlan
Journal:  J Virol       Date:  1999-12       Impact factor: 5.103

8.  Repression of enhancer II activity by a negative regulatory element in the hepatitis B virus genome.

Authors:  W Y Lo; L P Ting
Journal:  J Virol       Date:  1994-03       Impact factor: 5.103

9.  Selective reovirus infection of murine hepatocarcinoma cells during cell division. A model of viral liver infection.

Authors:  J Taterka; M Sutcliffe; D H Rubin
Journal:  J Clin Invest       Date:  1994-07       Impact factor: 14.808

10.  Functional interaction of nuclear factors EF-C, HNF-4, and RXR alpha with hepatitis B virus enhancer I.

Authors:  A D Garcia; P Ostapchuk; P Hearing
Journal:  J Virol       Date:  1993-07       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.